Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free EYPT Stock Alerts

Eyepoint Pharmaceuticals (EYPT) Short Interest Ratio & Short Volume

Eyepoint Pharmaceuticals logo
$12.97 -0.88 (-6.35%)
As of 03:20 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Eyepoint Pharmaceuticals Short Interest Overview

As of June 30, 2026, Eyepoint Pharmaceuticals (EYPT) had a short interest of 15.11 million shares sold short, representing 19.00% of the public float. This marks a 0.25% increase in short interest since the prior report. The short interest ratio (days to cover) is 9.6, meaning it would take 9.6 days of the average trading volume of 1.23 million shares to cover all short positions.

Current Short Interest
15,114,767 shares
Previous Short Interest
15,077,303 shares
Change Vs. Previous Month
0.25%
Dollar Volume Sold Short
$215.76 million
Short Interest Ratio
9.6 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
83,841,000 shares
Short Percent of Float
19.00%
Today's Trading Volume
1,119,016 shares
Average Trading Volume
1,230,777 shares
Today's Volume Vs. Average
91%
Short Selling Eyepoint Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EYPT Short Interest Over Time

EYPT Days to Cover Over Time

EYPT Percentage of Float Shorted Over Time

Eyepoint Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202615,114,767 shares $215.76 million +0.3%19.0%9.61 $14.28
6/15/202615,077,303 shares $182.13 million -0.1%19.0%13.84 $12.08
5/29/202615,097,978 shares $205.03 million +6.7%19.0%15.09 $13.58
5/15/202614,152,914 shares $174.79 million -0.2%17.7%16.88 $12.35
4/30/202614,186,473 shares $187.26 million +3.9%17.7%16.59 $13.20
4/15/202613,659,042 shares $199.83 million +2.0%17.2%15.93 $14.63
3/31/202613,385,952 shares $172.54 million +7.3%16.8%14.06 $12.89
3/13/202612,478,689 shares $164.72 million +14.8%15.7%7.52 $13.20
2/27/202610,868,767 shares $190.86 million +14.1%13.6%4.51 $17.56
2/13/20269,529,005 shares $123.31 million +10.3%12.0%7.86 $12.94
1/30/20268,638,845 shares $116.80 million +4.4%10.9%9.51 $13.52
1/15/20268,272,026 shares $131.03 million -4.2%10.5%8.54 $15.84
12/31/20258,632,273 shares $157.71 million +18.1%10.9%6.61 $18.27
12/15/20257,308,090 shares $119.85 million -7.3%9.2%6.63 $16.40
11/28/20257,881,028 shares $116.88 million -8.7%10.0%7.08 $14.83
11/14/20258,632,226 shares $99.96 million +14.2%13.1%5.88 $11.58
10/31/20257,558,136 shares $98.94 million -7.0%11.5%5.85 $13.09
10/15/20258,130,000 shares $95.36 million +1.6%12.3%8.1 $11.73
9/30/20258,000,000 shares $113.92 million -10.0%N/A9.6 $14.24
9/15/20258,890,000 shares $119.21 million +5.2%N/A11.2 $13.41
8/31/20258,450,000 shares $97.77 million +9.9%12.8%11.5 $11.57
8/15/20257,690,000 shares $85.28 million +11.3%N/A9.8 $11.09
7/31/20256,910,000 shares $67.86 million +2.8%10.5%8.9 $9.82
7/15/20256,720,000 shares $66.12 million -3.0%N/A8.4 $9.84
6/30/20256,930,000 shares $65.21 million +2.8%10.5%8.3 $9.41
6/15/20256,740,000 shares $60.86 million -6.0%10.3%8.1 $9.03
5/31/20257,170,000 shares $51.70 million -0.6%11.0%8.6 $7.21
5/15/20257,210,000 shares $41.24 million -28.4%11.1%9.2 $5.72
4/30/202510,070,000 shares $68.68 million -14.8%N/A12.4 $6.82
4/15/202511,820,000 shares $67.02 million +8.1%18.2%14 $5.67
3/31/202510,930,000 shares $59.24 million +0.9%16.8%12.8 $5.42
3/15/202510,830,000 shares $70.61 million +0.9%16.7%12.6 $6.52
2/28/202510,730,000 shares $67.28 million -3.3%16.5%12.4 $6.27
2/15/202511,090,000 shares $72.09 million +3.5%17.1%12.3 $6.50
1/31/202510,720,000 shares $82.01 million +1.3%N/A11.9 $7.65
1/15/202510,580,000 shares $81.36 million +2.3%N/A11 $7.69
12/31/202410,340,000 shares $77.03 million +9.9%N/A10.8 $7.45
12/15/20249,410,000 shares $70.20 million +1.7%N/A10.3 $7.46
11/30/20249,250,000 shares $81.86 million -6.4%N/A10.8 $8.85
11/15/20249,880,000 shares $90.60 million +2.1%N/A12.2 $9.17
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
10/31/20249,680,000 shares $113.84 million +5.6%N/A13.1 $11.76
10/15/20249,170,000 shares $90.60 million +2.7%N/A15.9 $9.88
9/30/20248,930,000 shares $71.35 million -1.9%N/A13.8 $7.99
9/15/20249,100,000 shares $82.81 million -0.1%N/A12.8 $9.10
8/31/20249,110,000 shares $81.53 million -3.9%N/A12.6 $8.95
8/15/20249,480,000 shares $77.74 million -0.7%N/A11.6 $8.20
7/31/20249,550,000 shares $94.35 million -5.3%N/A10.7 $9.88
7/15/202410,080,000 shares $106.24 million +4.7%N/A8.8 $10.54
6/30/20249,630,000 shares $83.78 million +7.2%N/A8.5 $8.70
6/15/20248,980,000 shares $84.23 million +16.0%N/A8.2 $9.38
5/31/20247,740,000 shares $82.90 million -4.8%N/A6.7 $10.71
5/15/20248,130,000 shares $105.20 million +23.2%N/A7 $12.94
4/30/20246,600,000 shares $116.16 million +0.9%N/A5.6 $17.60
4/15/20246,540,000 shares $139.17 million -4.5%N/A6.7 $21.28
3/31/20246,850,000 shares $141.59 million +4.1%N/A7.1 $20.67
3/15/20246,580,000 shares $141.34 million +15.0%N/A6.4 $21.48
2/29/20245,720,000 shares $155.64 million +20.4%N/A4.5 $27.21
2/15/20244,750,000 shares $138.13 million -7.6%N/A2.9 $29.08
1/31/20245,140,000 shares $138.42 million -1.2%N/A3.3 $26.93
1/15/20245,200,000 shares $118.35 million -2.4%N/A3.5 $22.76
12/31/20235,330,000 shares $123.18 million +12.2%N/A3.9 $23.11
12/15/20234,750,000 shares $92.86 million -32.2%N/A3.6 $19.55
11/30/20237,010,000 shares $43.81 million +28.9%25.0%5.9 $6.25
11/15/20235,440,000 shares $36.39 million +1.7%19.4%10.3 $6.69
10/31/20235,350,000 shares $32.21 million +9.0%19.2%10.3 $6.02
10/15/20234,910,000 shares $39.77 million -29.3%17.6%9.3 $8.10
9/30/20236,940,000 shares $55.45 million +12.3%25.1%11.6 $7.99
9/15/20236,180,000 shares $64.77 million +9.2%22.3%10.2 $10.48
8/31/20235,660,000 shares $56.09 million +12.1%20.6%9.5 $9.91
8/15/20235,050,000 shares $71.66 million +3.7%18.8%8.9 $14.19
7/31/20234,870,000 shares $60.88 million +1.9%N/A9.3 $12.50
7/15/20234,780,000 shares $52.44 million -7.7%N/A4.9 $10.97
6/30/20235,180,000 shares $45.07 million +7.5%N/A5.6 $8.70
6/15/20234,820,000 shares $32.73 million +13.2%18.4%5.3 $6.79
5/31/20234,260,000 shares $25.77 million +5.2%16.2%4.8 $6.05
5/15/20234,050,000 shares $24.30 million +11.3%15.4%4.7 $6.00
4/30/20233,640,000 shares $22.86 million -0.3%14.1%4.4 $6.28
4/15/20233,650,000 shares $15.80 million +9.3%14.2%5.3 $4.33
3/31/20233,340,000 shares $9.82 million +19.7%13.0%11 $2.94
3/15/20232,790,000 shares $6.67 million +34.8%10.9%10 $2.39
2/28/20232,070,000 shares $6.91 million No Change8.1%8.1 $3.34
2/15/20232,070,000 shares $7.66 million -4.2%8.1%8.5 $3.70
1/31/20232,160,000 shares $10.07 million +6.9%8.6%9.3 $4.66
1/15/20232,020,000 shares $10.18 million +13.5%8.0%9.4 $5.04
12/30/20221,780,000 shares $6.23 million +6.0%7.1%12.3 $3.50
12/15/20221,680,000 shares $4.50 million -2.9%6.7%11.6 $2.68
11/30/20221,730,000 shares $5.54 million -3.4%6.9%13.6 $3.20
11/15/20221,790,000 shares $7.91 million -9.1%7.1%14.1 $4.42
10/31/20221,970,000 shares $10.64 million -1.5%N/A16.1 $5.40
10/15/20222,000,000 shares $11.20 million -1.5%7.7%14.3 $5.60
Iran's New Leader Just Said Something That Should Terrify Every American (Ad)

Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel

Claim your free copy of The Great Gold Reset report today
9/30/20222,030,000 shares $16.06 million -0.5%7.8%12.5 $7.91
9/15/20222,040,000 shares $16.30 million +0.5%7.9%12.7 $7.99
8/31/20222,030,000 shares $20.30 million +1.5%7.8%12.7 $10.00
8/15/20222,000,000 shares $22.24 million -8.3%7.7%12.8 $11.12
7/31/20222,180,000 shares $19.90 million +7.4%8.3%13.8 $9.13
7/15/20222,030,000 shares $20.12 million +1.0%7.8%14.4 $9.91
6/30/20222,010,000 shares $15.82 million +2.0%7.7%16.8 $7.87
6/15/20221,970,000 shares $15.62 million -5.3%7.5%16.7 $7.93
5/31/20222,080,000 shares $20.07 million -3.3%8.0%16 $9.65
5/15/20222,150,000 shares $21.26 million -1.4%8.2%14.1 $9.89
4/30/20222,180,000 shares $24.63 million +0.5%8.3%13.4 $11.30
4/15/20222,170,000 shares $27.54 million +0.5%8.3%11.9 $12.69
3/31/20222,160,000 shares $26.24 million +4.9%8.3%9.6 $12.15
3/15/20222,060,000 shares $24.82 million +3.0%7.9%7.9 $12.05
2/28/20222,000,000 shares $19.90 million +3.6%7.7%7.2 $9.95
2/15/20221,930,000 shares $19.59 million -2.5%7.4%6.6 $10.15
1/31/20221,980,000 shares $18.55 million -8.3%7.6%2.4 $9.37
1/15/20222,160,000 shares $21.45 million +11.3%N/A2.7 $9.93
12/31/20211,940,000 shares $23.75 million +0.5%7.4%2.5 $12.24
12/15/20211,930,000 shares $28.27 million -3.5%7.4%2.6 $14.65
11/30/20212,000,000 shares $31.60 million +98.0%8.1%2.9 $15.80
11/15/20211,010,000 shares $14.44 million -34.0%4.2%1.5 $14.30
10/29/20211,530,000 shares $17.55 million +10.9%7.3%11 $11.47
10/15/20211,380,000 shares $15.79 million +0.7%6.6%12.1 $11.44
9/30/20211,370,000 shares $14.28 million -3.5%6.5%11.3 $10.42
9/15/20211,420,000 shares $14.31 million +2.9%6.8%8.4 $10.08
8/31/20211,380,000 shares $15.10 million +4.6%6.6%8.2 $10.94
8/13/20211,320,000 shares $13.66 million -4.4%6.3%8 $10.35
7/30/20211,380,000 shares $11.34 million +5.3%6.6%8.1 $8.22

EYPT Short Interest - Frequently Asked Questions

Short interest is the volume of Eyepoint Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 15,114,767 shares of EYPT short. 19.00% of Eyepoint Pharmaceuticals' shares are currently sold short. Learn More on Eyepoint Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EYPT shares currently have a short interest ratio of 9.6. Learn More on Eyepoint Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.00% of Eyepoint Pharmaceuticals' floating shares are currently sold short.

Eyepoint Pharmaceuticals saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 15,114,767 shares, an increase of 0.2% from the previous total of 15,077,303 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

19.00% of Eyepoint Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Eyepoint Pharmaceuticals: Vontier Corporation (7.92%), Mirion Technologies, Inc. (14.98%), Aehr Test Systems (14.21%), Alamar Biosciences, Inc. (4.03%), Allient Inc. (4.26%), Transcat, Inc. (5.99%), Frequency Electronics, Inc. (10.75%), Cytek Biosciences, Inc. (3.03%), Syntec Optics Holdings, Inc. (4.71%), Standard BioTools Inc. (1.20%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling EYPT is an investing strategy that aims to generate trading profit from Eyepoint Pharmaceuticals as its price is falling. EYPT shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eyepoint Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EYPT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EYPT, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EYPT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:EYPT) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.
Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...
Brownstone Research | Sponsoredtc pixel
URGENT Dollar Reset Warning for Monday
A 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...
Golden Portfolio | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
The committee no one knows
Trump's National Energy Dominance Council operates with no press conferences and little public coverage - yet ...
Behind the Markets | Sponsoredtc pixel
VWAV: Is This the Next Defense Breakout?
VisionWave Holdings (NASDAQ: VWAV) is developing a full-stack defense technology platform integrating AI, RF s...
Equiscreen | Sponsoredtc pixel